Skip to content

Study on the central mechanism of improving cervical vertigo by acupuncture based on EEG-fMRI

Study on the central mechanism of improving cervical vertigo by acupuncture based on EEG-fMRI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005589
Enrollment
Unknown
Registered
2022-02-02
Start date
2022-02-02
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical vertigo

Interventions

Sham acupuncture group:Sham acupuncture
Acupuncture Group:Rapid needling with filiform needle
Drug control group:Oral medication

Sponsors

Lianyungang Hospital of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) meeting the diagnostic criteria; (2) between the ages of 18 and 70, of both sexes; (3) stable condition, can complete with Dopler ultrasound examination; (4) those who have not received any other relevant treatment within one week; (5) good compliance, voluntary participation in clinical trials and active cooperation, agreed to sign an informed.consent form.

Exclusion criteria

Exclusion criteria: (1) those who do not meet the diagnostic criteria; (2) a woman who is pregnant or breastfeeding; (3) patients with cardiac cerebrovascular disease, autoimmune diseases, hepatic and renal dysfunction, psychosis, hematologic diseases and severe infections; (4) have a history of acupuncture dizziness or more difficult to bear the pain of acupuncture; (5) acute cervical disc injury, cervical fracture, dislocation, tumor and infection; (6) plain films showing physiological abnormalities of cervical spine structure, such as absence of pedicle or excessive length of transverse process; (7) peripheral vertigo caused by labyrinthitis, vestibular neuritis and positional vertigo, as well as central vertigo caused by intracranial vascular diseases, intracranial space-occupying lesions, intracranial infectious diseases and intracranial demyelinating diseases.

Design outcomes

Primary

MeasureTime frame
Functional magnetic resonance imaging;Transcranial Doppler;Electroencephalogram;

Secondary

MeasureTime frame
the vertigo symptom scale;vertigo disability assessment scale;modified cervical vertigo symptoms and function assessment scale;

Countries

China

Contacts

Public ContactQian Huang
heleiyui@163.com18705135858

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026